Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.

To order this 290+ page report, which features 120+ figures and 135+ tables, please visit this link

The USD 124 million (by 2030) financial opportunity within the in silico drug discovery market for large molecules has been analyzed across the following segments:
 Key Drug Discovery Steps
 Target Identification
 Target Validation
 Hit Generation
 Hit-to-Lead
 Lead Optimization

 Type of Large Molecule
 Antibodies
 Proteins
 Peptides
 Nucleic Acids
 Vectors

 Company Size
 Small
 Mid-sized
 Large

 Target therapeutic Area
 Autoimmune Disorders
 Blood Disorders
 Cardiovascular Disorders
 Gastrointestinal and Digestive Disorders
 Hormonal Disorders
 Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
 Infectious Diseases
 Metabolic Disorders
 Mental Disorders
 Musculoskeletal Disorders
 Neurological Disorders
 Oncological Disorders
 Respiratory Disorders
 Skin Disorders
 Urogenital Disorders
 Others

 Type of Sponsor
 Industry Players
 Non-Industry Players

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific

The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030, report features the following companies, which we identified to be key players in this domain:
 Abzena
 BioDuro
 BioNTech
 ChemPartner
 Creative Biostructure
 GenScript
 LakePharma
 Sundia MediTech
 Sygnature Discovery
 Viva Biotech

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Key Insights

6. Company Profiles

7. Company Competitiveness Analysis

8. Key Opportunity Areas

9. Emerging Business Models and Strategies

10. Case study: comparison of drug discovery processes of small molecules and large molecules

11. Survey insights

12. Cost saving analysis

13. Market Forecast

14. In silico tools and upcoming trends in drug discovery

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

18. Appendix 3: Non-Computational Methods for Drug Discovery

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]